Global DNA Synthesis Service Market Growth (Status and Outlook) 2026-2032
Description
The global DNA Synthesis Service market size is predicted to grow from US$ 1519 million in 2025 to US$ 3916 million in 2032; it is expected to grow at a CAGR of 14.5% from 2026 to 2032.
DNA Synthesis Service refers to professional outsourcing that manufactures custom DNA based on customer-provided sequence requirements, using chemical synthesis and/or enzymatic assembly, and delivers products in specified lengths, purity grades, formats, and documentation levels with appropriate quality control. Deliverables may include oligos, primers/probes, dsDNA fragments, cloned constructs, libraries, and site-directed variants, enabling broad applications across molecular diagnostics, vaccine and cell/gene therapy R&D, protein expression, synthetic biology, and biomanufacturing. Its core value is not merely “making the sequence,” but making it correct, consistent, and traceable to support rapid iteration, reproducibility, and compliance expectations.The average gross profit margin of this product is 55%.
Life-science innovation is moving toward platform-based engineering, where high-throughput workflows, lab automation, and AI-assisted design intensify demand for fast, reliable, and scalable DNA delivery. Expanding target exploration, personalized development, and small-batch prototyping increase the attractiveness of outsourced synthesis for speed, cost efficiency, and capacity flexibility. As global R&D collaboration deepens, providers with multi-region delivery capability, standardized documentation, and robust quality systems are better positioned to secure long-term partnerships.The key barriers are “system-level” quality and compliance capabilities. Long fragments, high-GC content, repetitive motifs, and structurally complex sequences can challenge success rates and consistency. Requirements vary sharply by application with respect to impurity control, sequence accuracy, endotoxin/bioburden control, and traceable documentation. In parallel, biosecurity and sequence-screening compliance, cross-border logistics, data/privacy management, and volatility in upstream materials and equipment can introduce uncertainty in lead times and costs, testing operational resilience and risk control.Customers are shifting from “buying fragments” to “buying efficiency and outcomes,” emphasizing predictable turnaround, high first-pass success, ready-to-use deliverables, and seamless integration with automation, verification, and data management. Service models are becoming more integrated—spanning manufacturability assessment, construct assembly, cloning/amplification, and selected validation support—forming end-to-end R&D acceleration offerings. Project-based, platform-based, and capacity-reservation collaboration models are also becoming more common to match continuous iteration cycles.Upstream essentials include nucleoside building blocks and protecting-group chemistries, solid supports/resins, coupling/oxidation/deprotection reagents and high-purity solvents for oligo synthesis; polymerases/ligases and buffer systems for enzymatic assembly; and the instruments, purification systems, analytical consumables, and single-use lab supplies that shape capacity and quality stability. Going forward, availability and batch consistency of critical inputs, compliant sourcing and supply security for key chemicals and enzymes, and standardized, automated QC systems will directly influence delivery quality, cost structure, and scalable growth.
LPI (LP Information)' newest research report, the “DNA Synthesis Service Industry Forecast” looks at past sales and reviews total world DNA Synthesis Service sales in 2025, providing a comprehensive analysis by region and market sector of projected DNA Synthesis Service sales for 2026 through 2032. With DNA Synthesis Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DNA Synthesis Service industry.
This Insight Report provides a comprehensive analysis of the global DNA Synthesis Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on DNA Synthesis Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global DNA Synthesis Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DNA Synthesis Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DNA Synthesis Service.
This report presents a comprehensive overview, market shares, and growth opportunities of DNA Synthesis Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Oligonucleotide Synthesis
Gene Synthesis
Segmentation by Use Case:
PCR
Sequencing
Expression/Research
Biomanufacturing
Segmentation by Technology Route:
Chemical Synthesis
Enzymatic Synthesis
Segmentation by Application:
Commercial
Academic Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Genescript
Thermo Fisher Scientific
IDT
Eurofins Genomics
DNA 2.0 (ATUM)
BBI
Azenta Life Sciences
SBS Genetech
Bio Basic
Twist Bioscience
OriGene
Bioneer
Eton Bioscience
Synbio Technologies
Eurogentec
Please note: The report will take approximately 2 business days to prepare and deliver.
DNA Synthesis Service refers to professional outsourcing that manufactures custom DNA based on customer-provided sequence requirements, using chemical synthesis and/or enzymatic assembly, and delivers products in specified lengths, purity grades, formats, and documentation levels with appropriate quality control. Deliverables may include oligos, primers/probes, dsDNA fragments, cloned constructs, libraries, and site-directed variants, enabling broad applications across molecular diagnostics, vaccine and cell/gene therapy R&D, protein expression, synthetic biology, and biomanufacturing. Its core value is not merely “making the sequence,” but making it correct, consistent, and traceable to support rapid iteration, reproducibility, and compliance expectations.The average gross profit margin of this product is 55%.
Life-science innovation is moving toward platform-based engineering, where high-throughput workflows, lab automation, and AI-assisted design intensify demand for fast, reliable, and scalable DNA delivery. Expanding target exploration, personalized development, and small-batch prototyping increase the attractiveness of outsourced synthesis for speed, cost efficiency, and capacity flexibility. As global R&D collaboration deepens, providers with multi-region delivery capability, standardized documentation, and robust quality systems are better positioned to secure long-term partnerships.The key barriers are “system-level” quality and compliance capabilities. Long fragments, high-GC content, repetitive motifs, and structurally complex sequences can challenge success rates and consistency. Requirements vary sharply by application with respect to impurity control, sequence accuracy, endotoxin/bioburden control, and traceable documentation. In parallel, biosecurity and sequence-screening compliance, cross-border logistics, data/privacy management, and volatility in upstream materials and equipment can introduce uncertainty in lead times and costs, testing operational resilience and risk control.Customers are shifting from “buying fragments” to “buying efficiency and outcomes,” emphasizing predictable turnaround, high first-pass success, ready-to-use deliverables, and seamless integration with automation, verification, and data management. Service models are becoming more integrated—spanning manufacturability assessment, construct assembly, cloning/amplification, and selected validation support—forming end-to-end R&D acceleration offerings. Project-based, platform-based, and capacity-reservation collaboration models are also becoming more common to match continuous iteration cycles.Upstream essentials include nucleoside building blocks and protecting-group chemistries, solid supports/resins, coupling/oxidation/deprotection reagents and high-purity solvents for oligo synthesis; polymerases/ligases and buffer systems for enzymatic assembly; and the instruments, purification systems, analytical consumables, and single-use lab supplies that shape capacity and quality stability. Going forward, availability and batch consistency of critical inputs, compliant sourcing and supply security for key chemicals and enzymes, and standardized, automated QC systems will directly influence delivery quality, cost structure, and scalable growth.
LPI (LP Information)' newest research report, the “DNA Synthesis Service Industry Forecast” looks at past sales and reviews total world DNA Synthesis Service sales in 2025, providing a comprehensive analysis by region and market sector of projected DNA Synthesis Service sales for 2026 through 2032. With DNA Synthesis Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DNA Synthesis Service industry.
This Insight Report provides a comprehensive analysis of the global DNA Synthesis Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on DNA Synthesis Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global DNA Synthesis Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DNA Synthesis Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DNA Synthesis Service.
This report presents a comprehensive overview, market shares, and growth opportunities of DNA Synthesis Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Oligonucleotide Synthesis
Gene Synthesis
Segmentation by Use Case:
PCR
Sequencing
Expression/Research
Biomanufacturing
Segmentation by Technology Route:
Chemical Synthesis
Enzymatic Synthesis
Segmentation by Application:
Commercial
Academic Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Genescript
Thermo Fisher Scientific
IDT
Eurofins Genomics
DNA 2.0 (ATUM)
BBI
Azenta Life Sciences
SBS Genetech
Bio Basic
Twist Bioscience
OriGene
Bioneer
Eton Bioscience
Synbio Technologies
Eurogentec
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
114 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 DNA Synthesis Service Market Size by Player
- 4 DNA Synthesis Service by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global DNA Synthesis Service Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
